Nutritional High International Inc. Ordinary Shares C.NHL

Primary Symbol: SPLID

High Fusion Inc is engaged in the manufacturing, processing, and distribution of infused edible products. The company's operating and geographical segments include Palo Verde; Pasa Verde; Oregon; Colorado; Nevada and Washington. It generates maximum revenue from the Palo Verde segment.

OTCPK:SPLID - Post by User

Nutritional High International Inc. Ordinary Shares > How much does everything think we will pay

<< Previous

Bullboard Posts

Next >>

Comment by stockveton Jul 17, 2018 4:22pm

144 Views

Post# 28329259

RE:How much does everything think we will pay

Ok so I used to think you were a serious investor, but it seems that you are just gambling on feelings and such! The transaction's terms was clearly stated in the initial news release of the 75% acquisition.

Of course, it may be subject to change but here's to give you the general idea...Reference

Proposed Transaction Highlights:

As consideration for the Acquisition the Company will:

(a) subscribe for 25% of the units of Green Therapeutics for aggregate process of US$6,000,000. US$2,000,000 of the subscription price would be paid on closing with the remaining US$4,000,000 paid in US$2,000,000 increments on specific dates to be agreed upon. It is intended that the proceeds of this subscription will be used to add 40,000 square feet to Green Therapeutics existing grow operations;

(b) the Company will purchase 25% of the outstanding units of Green Therapeutics from certain of the members of Green Therapeutics in exchange for common shares in the capital of the Company having a value of US$6,000,000. The number of common shares of the Company to be issued will be the lower of US$0.55 per common share or the 20-day volume weighted average price (in US dollars) of the Company’s common shares on the Canadian Securities Exchange on the date immediately preceding the date a definitive agreement in respect of the Acquisition is executed (the “Per Share Price“);

(c) the Company will purchase 25% of the outstanding units of Green Therapeutics from certain members of Green Therapeutics in exchange for secured convertible promissory notes having an aggregate original principal amount of $6,000,000. The notes would bear interest at a rate of 7% per annum, compounding annually, with all principal and accrued interest due and payable on the date which is 12 months from the date of issuance. The notes would be convertible at any time at the election of the holder(s) up to the maturity date into common shares of the Company at a conversion price equal to a 20% premium to the Per Share Price. The notes would rank pari-passu among each other and will be secured by the units of Green Therapeutics owned by the Company as well as the Property.